Form 13-F position report

CRYO-CELL INTL INC

Reported by Tower Research Capital LLC TRC

CCEL CUSIP 228895108 Manager CIK 0001533421

Reported 2,140 shares, down 626 (22.6%) from the prior quarter.

Reported value -38.1%; share count -22.6% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 2,140 Quarter-end amount reported
Reported value $13,000 Fair value at quarter end
Consecutive quarters held 4 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 0
2021-12-31 0
2022-03-31 21000
2022-06-30 13000
2022-09-30 8000
2022-12-31 9000
2023-03-31 11000
2023-06-30 517
2023-09-30 0
2024-09-30 3943
2024-12-31 7477
2025-03-31 11383
2025-06-30 2408
2025-09-30 5763
2025-12-31 4204
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for CRYO-CELL INTL INC held by Tower Research Capital LLC TRC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -1,222 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 1,222 -20 (-1.6%) < 0.01% $4,204 2026-02-17
Q3 2025 Added 1,242 +778 (167.7%) < 0.01% $5,763 2025-11-14
Q2 2025 Reduced 464 -1,323 (-74.0%) < 0.01% $2,408 2025-08-15
Q1 2025 Added 1,787 +778 (77.1%) < 0.01% $11,383 2025-05-15
Q4 2024 Added 1,009 +390 (63.0%) < 0.01% $7,477 2025-02-13
Q3 2024 New 619 +619 (0.0%) < 0.01% $3,943 2024-11-14
Q3 2023 Reduced 0 -85 (-100.0%) 0 $0 2023-11-14
Q2 2023 Reduced 85 -3,572 (-97.7%) < 0.01% $517 2023-08-14
Q1 2023 Added 3,657 +1,548 (73.4%) < 0.01% $11,000 2023-05-09
Q4 2022 Added 2,109 +822 (63.9%) < 0.01% $9,000 2023-02-10
Q3 2022 Reduced 1,287 -853 (-39.9%) < 0.01% $8,000 2022-11-10
Q2 2022 Reduced 2,140 -626 (-22.6%) < 0.01% $13,000 2022-08-15
Q1 2022 Added 2,766 +2,753 (21176.9%) < 0.01% $21,000 2022-05-12
Q4 2021 Added 13 +6 (85.7%) 0 $0 2022-02-14
Q3 2021 New 7 +7 (0.0%) 0 $0 2021-11-15

Who else reported the position

14 managers reported CRYO-CELL INTL INC for Q2 2022.

Managers reporting CRYO-CELL INTL INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ISZO CAPITAL MANAGEMENT LP Reduced 353,210 -3,897 3.27% $2,084,000 4 qtrs
SFI Advisors LLC Unchanged 165,300 0 1.08% $975,000 3 qtrs
MASSMUTUAL TRUST CO FSB ADV Added 124,135 +48,100 0.03% $732,000 13 qtrs
VANGUARD GROUP INC Unchanged 72,236 0 < 0.01% $426,000 3 qtrs
BlackRock Inc New 12,123 +12,123 < 0.01% $71,000 1 qtr
ROYAL BANK OF CANADA New 2,200 +2,200 < 0.01% $13,000 1 qtr
Tower Research Capital LLC TRC This report Reduced 2,140 -626 < 0.01% $13,000 4 qtrs
ADVISOR GROUP HOLDINGS INC Unchanged 2,000 0 < 0.01% $12,000 2 qtrs
Bank of America Corporation Reduced 1,000 -5,000 < 0.01% $6,000 4 qtrs
MORGAN STANLEY Added 800 +400 < 0.01% $5,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,140
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.